ASE Technology Holding Co., Ltd. (ASX) | The Buildout — AI Infrastructure

——Mkt cap — · 52-wk —–— · YTD — · delayed
Updated Sep 22, 2026Q2 FY2026 reviewed
ASE Technology packages and tests semiconductors, the assembly step AI accelerators must pass through.
Revenue +27% YoY
Q2 2026 net revenue NT$191.1B, up 26.7% year over year.
LEAP >$3.5B in 2026
LEAP advanced packaging is tracking ahead of the US$3.5B 2026 guide.
ATM 94% of profit
Assembly, testing and materials was 66% of revenue but 94% of operating profit.
FCF still negative
CapEx ~US$10.5B; management expects negative free cash flow to persist.
The Buildout Takeaway
Demand is not the constraint here; capacity is. Revenue and margins both rose as advanced packaging took a bigger share of profit, but the build-out is funded with debt and negative free cash flow, and management names its own execution as the binding limit.
5 analysts·4 Buy0 Hold1 Sell
Coverage is thin — no price estimates on file, so no target is shown

FY2026: ATM revenue +35% y/y · general segment +20% y/y · EMS sub-20% growth · CapEx ~US$10.5B · effective tax rate 18%
Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.
Our View

The Verdict

ASE Technology takes finished wafers from foundries and turns them into packaged, tested chips — and, through a separate division, builds the boards and modules that go into servers, PCs and communications gear. It does not design chips and does not sell AI systems. Its role in the build-out is the assembly and test step: leading-edge AI accelerators need 2.5D and 3D packaging to attach high-bandwidth memory and stitch chiplets together, and that step is capacity-constrained. The company describes itself as a pure-play OSAT — an outsourced semiconductor assembly and test provider — with no conflict with the foundry or the substrate supplier.

Market Cap—
Revenue (TTM)$22.8B
Revenue Growth+17.7%
EBITDA Margin (TTM)20.1%
Net Debt$5.9B
Earnings Beats5 of 7
P/E (TTM)—
EV/EBITDA (TTM)—

What We Like

  • Assembly, testing and materials was 66% of Q2 2026 revenue but 94% of operating profit, up from 61% and 87% a year earlier.
  • Management says leading-edge (LEAP) revenue is tracking ahead of its US$3.5B 2026 guidance, plus 'another couple hundred million dollars,' and aims to double that business again in 2027.
  • The general/mainstream segment guide was raised to 20% y/y from 13%, with management citing strong demand in industrial, power, connectivity and storage devices.
  • ATM gross margin was 27.3% in Q2 2026, guided to 28%–29% in Q3, and management expects Q4 to exceed its 30% structural ceiling.

What We’re Watching

  • Free cash flow is negative and expected to stay there — management says 'the negative cash flow situation will remain for some time' with CapEx at ~US$10.5B. Debt rose TWD 40.9B in Q2 2026 to TWD 306.2B; net debt/equity is 47%.
  • Execution is the stated binding constraint. 13 greenfield and 7–8 brownfield projects are running at once, and the 310×310 panel line's production start moved from end-2026 to Q1 2027.
  • EMS is the low-margin block: 2.4% operating margin in Q2 2026, and the Q3 revenue guide of +~40% q/q is largely memory component price pass-through rather than volume.
  • One unnamed customer accounted for more than 10% of operating revenue in each of FY2023–FY2025 — roughly a quarter of FY2025 revenue — and the relationship spans packaging and EMS.
Bottom Line

The thesis reads as strengthening on the business, with the balance sheet carrying the strain. Management raised rather than trimmed every quantitative guide in the record — LEAP, the general segment, CapEx and the ATM margin ceiling — and the profit mix moved further toward the high-margin assembly-and-test segment. The open questions are whether Q4 2026 ATM gross margin actually clears 30% and management formally raises its structural range, and whether the capacity program lands on time.

Next upThe next signposts are the Q4 2026 ATM gross margin print against the 30% structural ceiling and the 2027 CapEx sizing, which management deferred by 'another quarter or so.' Both test whether today's margin and spending levels are structural rather than cyclical.
Last Quarter — Q2 FY2026

Earnings Beat

Q2 2026 net revenue was NT$191.1B, up 26.7% year over year and 10.0% sequentially. Consolidated gross margin was 21.0%, up 1pp from the prior quarter and 4pp a year earlier, and operating margin was 11.1%. Net income was TWD 21.1B. The standout was the assembly, testing and materials segment, where revenue of TWD 126.1B was a record, up 36% year over year and 12% sequentially.

MetricQ2 FY2026Q1 FY2026Q2 FY2025YoY
Revenue$6.0B$5.5B$4.9B+23.0%
Gross margin21.0%20.1%16.1%+490bps
EBITDA$1.3B$1.1B$865M+49.3%
EPS$0.29$0.20$0.11+165.3%
ATM revenueTWD 126.1Bn/an/a+36% y/y
As business momentum continues to be very strong, we are aiming to double our LEAP revenue in 2027.— Joseph Tung, CFO, 2026-07-30

Management tone: Management's tone shifted most on margins. In February, the CFO said 'the price hike is not part of the structure margin' and deflected a question about the 30% ceiling. In July he volunteered that Q4 ATM gross margin will likely exceed that ceiling and that the structural range will be reviewed — 'when I say adjust, I mean upward adjustment.' Tone on pricing became more emphatic, and the CapEx language moved from a machinery top-up to a program with 70% of equipment CapEx for leading edge and 'we are not going to be shy.' At the same time, management repeatedly declined to size 2027 items, deferring them by stated periods rather than avoiding them.

Management Guidance

For Q3 2026, management guided consolidated revenue to +21% to +22% q/q in NT$ (assuming USD 1 = TWD 31.9), consolidated operating margin to 11.5%–12.5%, ATM revenue to +11% to +13% q/q and ATM gross margin to 28%–29%. It guided EMS revenue to +~40% q/q and EMS operating margin to 3.2%–3.4%, noting the EMS revenue step is largely memory component price pass-through and that ex-memory margin would be about 3.7%–3.8%. The consolidated gross-margin guide was recorded as printed at 12.5% to 21.5%, a lower bound the source flags as anomalous against Q2's 21.0%. For the full year, guidance is ATM revenue +35% y/y, general segment +20% y/y, EMS sub-20% growth, CapEx raised by another USD 2B (USD 4B facilities + USD 6.5B equipment) and an 18% effective tax rate.

Business Trajectory

Trajectory

On the audited quarterly series, revenue ran $5,537M, $5,732M, $5,494M and $6,001M over the last four quarters — a dip in the March 2026 quarter, then a 9.2% sequential rebound. Gross margin expanded from 17.1% to 21.0% over the same stretch and EBITDA margin from 17.9% to 21.5%. Management ties the gain to mix: assembly, testing and materials is growing faster than EMS and taking a larger share of profit, with LEAP advanced packaging leading. The cost of that mix shift shows up in cash, where management says the heavy CapEx program means 'the negative cash flow situation will remain for some time.'

Revenue & Margin Trajectory
RevenueGross margin$0$2.5B$5.0B$2.2B$2.9B$3.5B$3.7B$2.9B$2.9B$3.8B$3.9B$3.2B$3.6B$4.2B$5.3B$4.3B$4.5B$5.4B$6.2B$5.2B$5.5B$6.2B$5.6B$4.3B$4.4B$4.9B$5.1B$4.2B$4.3B$5.0B$5.0B$4.5B$4.9B$5.5B$5.7B$5.5B$6.0B15%21%Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
RevenueGross margin$0$2.5B$5.0B$2.2B$2.9B$3.5B$3.7B$2.9B$2.9B$3.8B$3.9B$3.2B$3.6B$4.2B$5.3B$4.3B$4.5B$5.4B$6.2B$5.2B$5.5B$6.2B$5.6B$4.3B$4.4B$4.9B$5.1B$4.2B$4.3B$5.0B$5.0B$4.5B$4.9B$5.5B$5.7B$5.5B$6.0B15%21%Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
Gross margin as reported.
Share Price — 12 Months
$20$40$052-wk high $43Sep '25DecMar '26JunSep '26
52-week range $11–$43.
Share Price — 12 Months
$20$40$052-wk high $43Sep '25DecMar '26JunSep '26
52-week range $11–$43.
The Numbers

The Model

The model's locked projections put FY+1 revenue at $26,345.0M with EBITDA of $5,849M (22.2%), rising to FY+2 revenue of $32,961.0M with EBITDA of $7,878M (23.9%). The near-term anchor is the capacity program already underway — 13 greenfield and 7–8 brownfield projects that management says carry the company into 2028 — plus LEAP tracking ahead of US$3.5B in 2026. The FY+2 step rests on LEAP doubling again in 2027, the 310×310 panel line entering production in Q1 2027, and the general segment holding its raised 20% growth rate.

Revenue & EBITDA Projections
REVENUE$20.7B$26.3B$33.0BFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$3.8B$5.8B$7.9B23.9%FY25FY+1 (E)FY+2 (E)
REVENUE$20.7B$26.3B$33.0BFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$3.8B$5.8B$7.9B23.9%FY25FY+1 (E)FY+2 (E)
Solid bars are reported actuals; outlined bars are model projections — not company guidance.
MetricFY2025Next FY (E)Following FY (E)
Revenue$20.7B$26.3B$33.0B
YoY Growth—+27.5%+25.1%
EBITDA$3.8B$5.8B$7.9B
EBITDA Margin18.3%22.2%23.9%

Projections are the median of 4 independent model runs. The model’s revenue sits 7.5% above analyst consensus.

For Q3 2026, management guided consolidated revenue to +21% to +22% q/q in NT$ (assuming USD 1 = TWD 31.9), consolidated operating margin to 11.5%–12.5%, ATM revenue to +11% to +13% q/q and ATM gross margin to 28%–29%. It guided EMS revenue to +~40% q/q and EMS operating margin to 3.2%–3.4%, noting the EMS revenue step is largely memory component price pass-through and that ex-memory margin would be about 3.7%–3.8%. The consolidated gross-margin guide was recorded as printed at 12.5% to 21.5%, a lower bound the source flags as anomalous against Q2's 21.0%. For the full year, guidance is ATM revenue +35% y/y, general segment +20% y/y, EMS sub-20% growth, CapEx raised by another USD 2B (USD 4B facilities + USD 6.5B equipment) and an 18% effective tax rate.

What Could Go Right — and Wrong

What good looks like
  • Q4 2026 ATM gross margin clears the 30% structural ceiling and management formally raises the structural range — the cleanest test of whether today's margin is structural.
  • The deferred 2027 LEAP disclosure shows a mix skewing toward full-process and test; testing carried the highest segment gross margin in the FY2025 filing at 31.0%.
  • The 310×310 panel line begins production in Q1 2027.
  • The general segment holds its raised 20% growth rate, making legacy wire bond and traditional advanced packaging a second engine rather than a runoff.
  • The 20-plus construction projects land on schedule, converting the capacity program into revenue without further slippage.
What could go wrong
  • Free cash flow stays negative longer than the CapEx cycle; debt rose TWD 40.9B in one quarter to TWD 306.2B and net debt/equity is 47%.
  • One unnamed customer at roughly a quarter of FY2025 revenue changes its sourcing or package architecture — a group-level event.
  • A foundry decides to in-source advanced packaging at scale; the 20-F already names TSMC's InFO technology.
  • EMS profitability stays under pressure — Q2 2026 operating margin was 2.4% — and its revenue growth remains pass-through rather than volume.
  • Construction or equipment installation slips further, pushing capacity additions and the panel line start beyond Q1 2027.
What’s Next

Looking Ahead

The next twelve months turn on a small number of dated signposts. Management has said Q4 2026 ATM gross margin will likely exceed the 30% structural ceiling, with a review of the range to follow. It has deferred 2027 CapEx sizing by about a quarter, and the 2027 LEAP composition plus CPO revenue detail by about two. The 310×310 panel line is guided to start production in Q1 2027, and CPO is expected to launch toward the end of the year in small volume. Underneath all of it sits one question: whether the construction program converts demand into revenue on time.

Catalysts
  • 2H 2026ATM opex ratio trend — Company expects the ATM operating-expense ratio to keep improving.
  • Q4 2026ATM margin vs 30% — Tests whether ATM gross margin clears the 30% structural ceiling.
  • End of yearCPO small-volume launch — Optical/CPO starts shipping in small volume; volumes and yields unknown.
  • Next quarter or so2027 CapEx sizing — Management deferred the 2027 CapEx number by about a quarter.
  • Q1 2027Panel line production start — 310×310 fully automated panel-level packaging line begins production.
  • 2027LEAP revenue doubling — Tests the target of doubling LEAP revenue on top of 2026's base.
Numbers

Financials

Annual Summary

MetricFY2024FY2025TTMYoY
Revenue$18.5B$20.7B$22.8B+11.4%
Gross Margin15.4%17.1%19.5%+175bps
EBITDA$3.1B$3.8B$4.6B+22.9%
EBITDA Margin16.6%18.3%20.1%+170bps
Net Income$1.0B$1.3B$1.9B+28.9%
Free Cash Flow$170M−$7.2B−$7.9B—
Net Cash————

Key Ratios (Trailing)

Valuation
  • P/E TTM—
  • EV/EBITDA TTM—
  • EV/Revenue TTM—
  • Price/FCF TTM—
Profitability
  • Gross Margin (TTM)19.5%
  • EBITDA Margin (TTM)20.1%
  • Net Margin (TTM)8.5%
  • ROIC9.7%
  • FCF Conversion-172.1%
  • SBC / Revenue0.0%
Reference

The Company

ASE Technology Holding is an outsourced semiconductor assembly and test provider — an OSAT — and an electronics manufacturing services company. It takes finished wafers from foundries and turns them into packaged, tested, shippable semiconductors. Its services run from semiconductor packaging and production of interconnect materials through front-end engineering testing, wafer probing and final testing, plus integrated EMS solutions for computing, peripherals, communications, industrial, automotive and server applications. That matters to the AI build-out because leading-edge accelerators need 2.5D and 3D packaging, and the 20-F lists CoWoS, CoPoS, CoWoP, CPO and 3D IC inside the ordinary packaging product map rather than as side projects.

The company operates at unusual physical scale. As of January 31, 2026 it had 25,001 wire bonders, 7,456 testers and 205 SMT lines, and at the end of 2025 it had 105,947 employees, with 6,358 patents held and 2,249 applications pending. Primary packaging and testing is in Kaohsiung, Taiwan, with further integrated packaging and test sites in Taiwan, China, Malaysia, South Korea, Japan, Singapore and the Philippines, plus a Northern California front-end engineering and final-test facility placed near large fabless design companies. The EMS arm, USI Group, spans Vietnam, Mexico, Poland, Hungary, Germany, the UK, France, Tunisia, the Czech Republic and China.

Business Segments

Packaging
FY2025 NT$308.3B / US$9,829.2M (20-F segment table)
Flip chip BGA and CSP, QFP/LQFP/TQFP, QFN/aQFN and plastic BGA, plus advanced packages including 2.5D, CoWoS, CoPoS, CoWoP, CPO and 3D IC.
Growth driver: Advanced packaging and the LEAP ramp
Testing
FY2025 NT$71.9B / US$2,292.0M (20-F segment table)
Front-end engineering testing, wafer probing, and final testing of logic, mixed-signal and RF chips plus SiP/MEMS/discrete modules.
Growth driver: Probe-intensive leading-edge work
EMS
FY2025 NT$257.2B / US$8,198.7M (20-F segment table)
Through USI Group: server and PC motherboards, AI cards, Wi-Fi, SiP, automotive EMS and automotive wireless solutions.
Growth driver: AI accelerator products inside the computing category

Competitive Landscape

The competitive dynamic the source describes is one of scale and neutrality rather than a single rival. The 20-F notes that foundries offer their own advanced packaging — it names TSMC's integrated fan-out, InFO — while Amkor's filings name 'ASE Technology, JCET Group and Powertech Technology' as competitors. ASE counters with a pure-play framing: management says it has 'no conflict with foundry, with no conflict with substrate provider. We have no conflict with anybody,' which it says lets it cooperate across CoWoS, EMIB and alternative architectures.

  • TSMC
    The 20-F says TSMC has offered advanced packaging technologies such as integrated fan-out (InFO).
  • Amkor (AMKR)
    Amkor's own filing names ASE Technology among its competitors. An analyst on the July call framed Amkor as more aggressive in U.S. operations.
  • JCET Group
    Named alongside ASE in Amkor's competitor list; not discussed further in the source material.
  • Powertech Technology
    Named alongside ASE in Amkor's competitor list; not discussed further in the source material.
  • KYEC
    Referenced by an analyst on the July call alongside Amkor for announced U.S. operations; no specific figure given.
TSMC is named in the 20-F and by management on the July 2026 call; Amkor is documented through Amkor's own filing naming ASE as a competitor, which is also the source of the JCET and Powertech rows as carried in the wiring file; KYEC comes from an analyst question on the same call.

Supply Chain

ASE sits between the foundries that make wafers and the chip designers and system builders that ship products. Its inputs are wafers, IC substrates and packaging materials; its outputs are finished, tested chips and assembled modules.

Supplier
Kinsus Interconnect Technology
IC substrates; named among a limited number of suppliers in the 20-F
Supplier
Nan Ya Printed Circuit Board
IC substrates; named among a limited number of suppliers in the 20-F
Supplier
Unimicron Technology
IC substrates; named among a limited number of suppliers in the 20-F
Supplier
Silicone-based materials; received the 2025 ASE Best Supplier Award
→
Pure-play OSAT with scale
ASX
Assembly, packaging and test across Taiwan, China, Malaysia, Korea, Japan, Singapore, the Philippines and Northern California, plus worldwide EMS.
→
One unnamed customer
Approximately 25% of FY2025 revenue
More than 10% of operating revenue in FY2023–FY2025; packaging and EMS

Analysis updated Sep 22, 2026, reviewing Q2 FY2026. Prices delayed. Built with The Buildout’s published methodology. Not investment advice. No positions held. © The Buildout 2026.

More on ASX: Earnings recap